This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Academia Sinica, National Yang Ming Chiao Tung University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 728 
1 out of 1,249 Years Active: 2023
Title: Innovations of Wen-Hsin Li in Metabolic Disorder Treatment
Introduction
Wen-Hsin Li is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of metabolic disorder treatment through his innovative research and patent.
Latest Patents
Wen-Hsin Li holds a patent for a method aimed at preventing or treating metabolic disorders. This method involves administering a therapeutically effective amount of TRABID protein or a functionally related variant, as well as a nucleic acid encoding TRABID protein. Additionally, his patent outlines a method for reducing fat accumulation by promoting autophagy activity and lipid metabolism through TRABID-induced deubiquitination.
Career Highlights
Throughout his career, Wen-Hsin Li has worked with prestigious institutions such as Academia Sinica and National Yang Ming Chiao Tung University. His work has been instrumental in advancing the understanding and treatment of metabolic disorders.
Collaborations
Wen-Hsin Li has collaborated with notable colleagues, including Ruey-Hwa Chen and Yu-Hsuan Chen, who have contributed to his research endeavors.
Conclusion
Wen-Hsin Li's innovative approach to treating metabolic disorders showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile